BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Optimer Pharmaceuticals, Inc. 

10110 Sorrento Valley Road
Suite C
San Diego  California  92121  U.S.A.
Phone: 858-909-0736 Fax: 858-909-0737


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
AstraZeneca PLC (AZN), Cubist Pharmaceuticals, Inc. (CBST), Astellas Pharma Inc. (YPH.BE) Said to Make Bids for Optimer Pharmaceuticals, Inc. (OPTR) 5/15/2013 8:19:07 AM    More...
Optimer Pharmaceuticals, Inc. (OPTR) Appoints Eric Sirota as Chief Operating Officer 5/14/2013 6:43:36 AM    More...
Optimer Pharmaceuticals, Inc. (OPTR) Reports First Quarter 2013 Financial Results 5/10/2013 6:28:37 AM    More...
Optimer Pharmaceuticals, Inc. (OPTR) to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results 5/2/2013 7:38:01 AM    More...
Optimer Pharmaceuticals, Inc. (OPTR)'s DIFICID® Tablets Approved in Australia 4/26/2013 7:09:42 AM    More...
Optimer Pharmaceuticals, Inc. (OPTR) Said to Draw Takeover Interest From GlaxoSmithKline (GSK), Astellas Pharma Inc. (YPH.BE) 4/2/2013 8:00:24 AM    More...
Optimer Pharmaceuticals, Inc. (OPTR) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/15/2013 10:14:08 AM    More...
Optimer Pharmaceuticals, Inc. (OPTR) Reports Fourth Quarter and Fiscal Year 2012 Financial Results 3/1/2013 7:40:39 AM    More...
Optimer Pharmaceuticals, Inc. (OPTR) Names Dr. Henry McKinnell as CEO 2/27/2013 7:26:35 AM    More...
Optimer Pharmaceuticals, Inc. (OPTR) Release: New Analysis Shows Age Has a Significant Effect on Outcomes in Patients Being Treated for Clostridium Difficile Infection (CDI) 2/14/2013 8:58:05 AM    More...
12345678910...